Editing Functional: Neuromodulation (section)

=== OnabotulinumtoxinA vs. Sacral Neuromodulation in Overactive Bladder ===
* The increasing use of OBTX in the therapy for OAB has yielded questions to how to decide whether to use OBTX or sacral neuromodulation in patients with refractory OAB.
* At present, patients with emptying disorders or those at risk for urinary retention who do not want to catheterize would not be ideal candidates for OBTX. Furthermore, these patients need to be aware of the re-treatment intervals approximately every 6 months and this may aid in decision making. On the contrary, if someone has neurogenic conditions, is not willing to undergo an implant (permanent), or may need future MRIs, sacral neuromodulation becomes a less attractive option.